A significant stride to uncover the unmet needs of Thai patients and to drive growth opportunities for both DKSH and Takeda.
Bangkok, August 15, 2022 – DKSH Business Unit Healthcare, Asia's leading partner for healthcare companies seeking to grow their business in Asia and beyond, has extended its partnership with Takeda (Thailand) Limited, a global, values-based, R&D-driven biopharmaceutical leader, to provide sales promotion in pharmacy channel operated in Thailand.
DKSH Thailand and Takeda Thailand have been working together for more than two decades to serving Thai patients with innovative medicines and healthcare solutions. The partnership is to reinforce Takeda’s leadership in the therapeutic area of gastroenterology, while leveraging DKSH’s large sales force, broad reach across the pharmacy channel, and strong ties with trade partners.
Peter Streibl, General Manager, Takeda Thailand, said "Gastroenterology is one of our core therapeutic areas where we are committed to addressing unmet medical needs for those living with gastrointestinal (GI) disease. We collaborate to form a partnership that makes the innovative treatments more accessible to those who are suffering with GI disease. Faithful to its commitment where the expansion into pharmacy channel is to solidify our leadership in gastroenterology, strengthen our presence in the market, and to support our long-standing commitment to resorting life to living for patients suffering with GI with innovative and life-transforming medicines.”
John Clare, Vice President Healthcare, DKSH Thailand & Indochina, commented “This partnership offers a great opportunity for us to expand our product portfolio to cover additional market segments and strengthen our position as a key player in Thailand’s pharmacy channel. Our extensive and experienced sales force along with our expertise in commercial outsourcing and tailored strategy to drive expansion will no doubt support Takeda to sustain its leadership position in this therapeutic area.”
About Takeda Pharmaceutical Company
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet.
About Takeda Thailand
Takeda Thailand was established in 1969 as the third branch under Takeda's global expansion plan. Takeda Thailand's core business portfolio includes innovations that can transform patients’ lives under key business areas: Gastro-enterology, Oncology, Rare Genetic and Immunology, and preparing for the anticipated launch of Vaccines.
About DKSH
At DKSH, our purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health and over-the-counter (OTC) products as well as medical devices. With around 7,920 specialists, the Business Unit generated net sales of CHF 5.4 billion in 2020. www.dksh.com/hec